Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Acute Kidney Injury D058186 34 associated lipids
Acute Lung Injury D055371 33 associated lipids
Mucositis D052016 7 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Atherosclerosis D050197 85 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Hyperuricemia D033461 4 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Fetal Weight D020567 12 associated lipids
Stroke D020521 32 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Migraine without Aura D020326 1 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Venous Thrombosis D020246 11 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Thrombophilia D019851 6 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Endotoxemia D019446 27 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Leukostasis D018921 1 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Pelvic Pain D017699 7 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Liver Failure D017093 5 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Asaka N et al. Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets. 2010 Arzneimittelforschung pmid:21117500
Natsume Y et al. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats. 1994 Arzneimittelforschung pmid:7848333
Tasaka K et al. Inhibitory effect of epinastine on bronchoconstriction induced by histamine, platelet activating factor and serotonin in guinea pigs and rats. 1994 Arzneimittelforschung pmid:7910745
Tanaka T et al. Effect of a novel xanthine derivative on experimental ulcers in rats. 1993 Arzneimittelforschung pmid:8329000
David S et al. Production of platelet activating factor by human neutrophils after backfiltration of endotoxin contaminated dialysate. 1993 Jul-Sep ASAIO J. pmid:8268642
Takayama K et al. Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. 1991 Jul-Sep ASAIO Trans pmid:1836334
Akizawa T et al. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis. 1991 Jul-Sep ASAIO Trans pmid:1751199
Ando M et al. Pregnancy suppression by a platelet activating factor antagonist, ONO-6240, in mice. 1990 Asia Oceania J Obstet Gynaecol pmid:2378595
Ando M et al. Pregnancy suppression by a structurally related antagonist for platelet activating factor, CV-6209, in mice. 1990 Asia Oceania J Obstet Gynaecol pmid:2088253
Roudebush WE Role of platelet-activating factor in reproduction: sperm function. 2001 Asian J. Androl. pmid:11404790
Tsai JJ et al. The modulatory effect of antigen- and PAF-induced asthmatic reaction by aerosol administration of OKY-046 in guinea pigs. 1995 Asian Pac. J. Allergy Immunol. pmid:8703249
Tsai JJ et al. Enhanced eosinophil luminol-dependent chemiluminescence and complement receptor expression by platelet-activating factor and interleukin-5. 1993 Asian Pac. J. Allergy Immunol. pmid:8216559
Tselepis AD and John Chapman M Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. 2002 Atheroscler Suppl pmid:12573364
Feliste R et al. Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta. 1989 Atherosclerosis pmid:2783199
Caslake MJ et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. 2000 Atherosclerosis pmid:10856534
Mügge A et al. Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo. 1992 Atherosclerosis pmid:1418094
Verouti SN et al. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects. 2011 Atherosclerosis pmid:21920519
Fiotti N et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 1999 Atherosclerosis pmid:10428295
Croft KD et al. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia. 1990 Atherosclerosis pmid:2173612
Violi F et al. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration. 1990 Atherosclerosis pmid:2115784
Deigner HP et al. Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes. 1999 Atherosclerosis pmid:10381281
Hasselwander O et al. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. 1999 Atherosclerosis pmid:10208487
Bochkov VN et al. Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins. 1992 Atherosclerosis pmid:1334652
Imaizumi T et al. Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins. 1991 Atherosclerosis pmid:1872924
Yamada Y et al. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population. 2000 Atherosclerosis pmid:10781653
Pégorier S et al. Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis. 2006 Atherosclerosis pmid:16386258
Tiniakou I et al. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice. 2015 Atherosclerosis pmid:26363436
Narita S and Asakura K The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs. 1993 Auris Nasus Larynx pmid:7905260
Tachibana F et al. Platelet-activating factor and leukotrienes in acute otitis media, secretory otitis media, and chronic otitis media on the acute excerbation. 1996 Auris Nasus Larynx pmid:8809319
Ogura M et al. Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle ear. 2008 Auris Nasus Larynx pmid:17997066
Morley J Asthma mortality and inhaled beta agonist therapy. 1992 Aust N Z J Med pmid:1359864
Jackson SP and Salem HH Platelet aggregating activity in the plasma of patients with established thrombosis. 1989 Aust N Z J Med pmid:2504137
Gillin AG Maintenance of high risk pregnancies: role of prostaglandins and other mediators. 1994 Aust N Z J Obstet Gynaecol pmid:7848215
Klopper A and Saunders DM Signals from the conceptus. 1994 Aust N Z J Obstet Gynaecol pmid:7531434
Cooper TM and Ingram DM Platelet function in the peri-operative period. 1991 Aust N Z J Surg pmid:1829351
Jobe LW et al. Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730. 1993 Autoimmunity pmid:8025205
Beck JC et al. Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat. 1991 Autoimmunity pmid:1777555
Jauchem JR The role of autacoids and the autonomic nervous system in cardiovascular responses to radio-frequency energy heating. 2006 Auton Autacoid Pharmacol pmid:16553641
Subbotina LA [Procedure of blood agregation system analysis]. 2006 Sep-Oct Aviakosm Ekolog Med pmid:17357632
Brady M et al. Cytokines and acute pancreatitis. 1999 Baillieres Best Pract Res Clin Gastroenterol pmid:11030606
Imrie CW and McKay CJ The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis. 1999 Baillieres Best Pract Res Clin Gastroenterol pmid:11030612
Harper MJ The implantation window. 1992 Baillieres Clin Obstet Gynaecol pmid:1424330
Ahmed AS and Smith SK The endometrium: prostaglandins and intracellular signalling at implantation. 1992 Baillieres Clin Obstet Gynaecol pmid:1335852
O'Neill C A consideration of the factors which influence and control the viability and developmental potential of the preimplantation embryo. 1991 Baillieres Clin Obstet Gynaecol pmid:1855338
Smith SK The role of prostaglandins in implantation. 1991 Baillieres Clin Obstet Gynaecol pmid:1855344
Bonney RC and Franks S The endocrinology of implantation and early pregnancy. 1990 Baillieres Clin. Endocrinol. Metab. pmid:1701083
Pearson JD The control of production and release of haemostatic factors in the endothelial cell. 1993 Baillieres Clin. Haematol. pmid:8025346
Ranasinghe S and Bolsover S Microglial calcium responses to platelet-activating factor are inhibited by analogue CAS 99103-16-9 and dihydropyridine PCA 4248 but not by ginkgolide A. 2004 Basic Clin. Pharmacol. Toxicol. pmid:15379786
Chu WF et al. Increasing Intracellular calcium of guinea pig ventricular myocytes induced by platelet activating factor through IP3 pathway. 2006 Basic Clin. Pharmacol. Toxicol. pmid:16433899
Droy-Lefaix MT et al. The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach. 1988 Basic Life Sci. pmid:3250539
Colton CA and Gilbert DL An endogenous source of the superoxide anion in the central nervous system. 1988 Basic Life Sci. pmid:2854971
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Napoli C et al. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein. 1997 Basic Res. Cardiol. pmid:9166989
Auchampach JA et al. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function. 1998 Basic Res. Cardiol. pmid:9833148
Felix SB et al. Cardiovascular reactions and respiratory events during platelet activating factor-induced shock. 1990 May-Jun Basic Res. Cardiol. pmid:2383216
Leprán I and Lefer AM Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. 1985 Mar-Apr Basic Res. Cardiol. pmid:4039929
Giessler C et al. Effects of PAF on cardiac function and eicosanoid release in the isolated perfused rat heart: comparison between normotensive and spontaneously hypertensive rats. 1995 Jul-Aug Basic Res. Cardiol. pmid:8534259
Saraf MK et al. Role of platelet activating factor in triazolobenzodiazepines-induced retrograde amnesia. 2003 Behav. Brain Res. pmid:12798263
Jerusalinsky D et al. Effect of antagonists of platelet-activating factor receptors on memory of inhibitory avoidance in rats. 1994 Behav. Neural Biol. pmid:7945139
Mutoh H et al. Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B. 1994 Biochem. Biophys. Res. Commun. pmid:7802642
Asano K et al. Distribution of platelet activating factor receptor mRNA along the rat nephron segments. 1996 Biochem. Biophys. Res. Commun. pmid:8753768
el Azzouzi B et al. Immunoregulatory functions of paf-acether. IX. Modulation of apoptosis in an immature T cell line. 1993 Biochem. Biophys. Res. Commun. pmid:8427577
Rengan R and Omann GM Regulation of oscillations in filamentous actin content in polymorphonuclear leukocytes stimulated with leukotriene B(4) and platelet-activating factor. 1999 Biochem. Biophys. Res. Commun. pmid:10462500
Naccache PH et al. Unique inhibitory profile of platelet activating factor induced calcium mobilization, polyphosphoinositide turnover and granule enzyme secretion in rabbit neutrophils towards pertussis toxin and phorbol ester. 1985 Biochem. Biophys. Res. Commun. pmid:2992480
Avdonin PV et al. Stimulation of high-affinity hormone-sensitive GTPase of human platelets by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphocholine (platelet activating factor). 1985 Biochem. Biophys. Res. Commun. pmid:2994653
Maridonneau-Parini I et al. Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pig. 1985 Biochem. Biophys. Res. Commun. pmid:2994661
López-Farré A et al. Glomeruli from ischemic rat kidneys produce increased amounts of platelet activating factor. 1988 Biochem. Biophys. Res. Commun. pmid:3358756
Kuiper J et al. The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells. 1988 Biochem. Biophys. Res. Commun. pmid:3144970
O'Flaherty JT et al. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation. 1981 Biochem. Biophys. Res. Commun. pmid:6277309
Touvay C et al. Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen- induced bronchoconstriction in the guinea-pig. 1989 Biochem. Biophys. Res. Commun. pmid:2775253
Bastien Y and Mazer BD Detection of the human platelet-activating factor receptor mRNA in human B lymphocytes by polymerase chain reaction on reverse transcripts (RT-PCR) 1994 Biochem. Biophys. Res. Commun. pmid:8060316
Wykle RL et al. Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils. 1981 Biochem. Biophys. Res. Commun. pmid:7295320
Franklin RA et al. Platelet activating factor activates MAPK and increases in intracellular calcium via independent pathways in B lymphocytes. 1995 Biochem. Biophys. Res. Commun. pmid:7733966
Gil MG et al. Inhibition of phospholipid methyltransferase during zymosan induced secretion of platelet-activating factor in human polymorphonuclear leukocytes. 1981 Biochem. Biophys. Res. Commun. pmid:7306113
White GC Effect of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine on calcium fluxes by human platelet microsomes. 1984 Biochem. Biophys. Res. Commun. pmid:6428395
Fukao M et al. Structural differences in the ability of lysophospholipids to inhibit endothelium-dependent hyperpolarization by acetylcholine in rat mesenteric arteries. 1996 Biochem. Biophys. Res. Commun. pmid:8878540
Resink T et al. Involvement of protein kinase C in hypoxia-induced desensitization of the beta-adrenergic system in human endothelial cells. 1996 Biochem. Biophys. Res. Commun. pmid:8651917
Fernández B and Balsinde J Receptor-mediated activation of arachidonic acid release in mouse peritoneal macrophages is linked to extracellular calcium influx. 1991 Biochem. Biophys. Res. Commun. pmid:1659393
Rigat B et al. GM2 activator protein inhibits platelet activating factor signaling in rats. 2009 Biochem. Biophys. Res. Commun. pmid:19486886
Lee TC et al. 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelets. 1981 Biochem. Biophys. Res. Commun. pmid:6797422
Fisher GJ et al. Differential activation of human skin cells by platelet activating factor: stimulation of phosphoinositide turnover and arachidonic acid mobilization in keratinocytes but not in fibroblasts. 1989 Biochem. Biophys. Res. Commun. pmid:2476985
Sakakibara M et al. Induction of photoresponse by the hydrolysis of polyphosphoinositides in the Hermissenda type B photoreceptor. 1994 Biochem. Biophys. Res. Commun. pmid:7518677
Joly F et al. Biosynthesis of paf-acether in cultured-mouse mast cells: the role of calcium and G proteins. 1992 Biochem. Biophys. Res. Commun. pmid:1317174
Maruyama Y et al. Thrombin receptor agonist peptide decreases thrombomodulin activity in cultured human umbilical vein endothelial cells. 1994 Biochem. Biophys. Res. Commun. pmid:8147869
Chen JJ and Liew CC Phosphorylation of an acid-soluble nuclear protein in response to catecholamine in cultured rat cardiocytes. 1993 Biochem. Biophys. Res. Commun. pmid:8439325
Sugiura T et al. 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells. 1996 Biochem. Biophys. Res. Commun. pmid:8954083
Scherer GF 1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) stimulates plant H+ transport in vitro and growth. 1985 Biochem. Biophys. Res. Commun. pmid:4084306
Slomiany BL and Slomiany A Platelet-activating factor modulates gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide. 2003 Biochem. Biophys. Res. Commun. pmid:12788098
Yamada T et al. Effects of YM264, a novel PAF antagonist, on puromycin aminonucleoside-induced nephropathy in the rat. 1991 Biochem. Biophys. Res. Commun. pmid:2025290
Matsumoto T et al. G-protein dissociation, GTP-GDP exchange and GTPase activity in control and PMA treated neutrophils stimulated by fMet-Leu-Phe. 1987 Biochem. Biophys. Res. Commun. pmid:3032170
O'Flaherty JT and Jacobson D Protein kinase C blockers and neutrophil receptors for leukotriene B4. 1989 Biochem. Biophys. Res. Commun. pmid:2551291
Dewald B and Baggiolini M Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4. 1985 Biochem. Biophys. Res. Commun. pmid:2985075
Gomez-Cambronero J et al. The diacylglycerol kinase inhibitor R59022 potentiates superoxide production but not secretion induced by fMet-Leu-Phe: effects of leupeptin and the protein kinase C inhibitor H-7. 1987 Biochem. Biophys. Res. Commun. pmid:2823810
Rouis M et al. Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages. 1988 Biochem. Biophys. Res. Commun. pmid:2847729
Doni MG et al. Forskolin and prostacyclin inhibit fluoride induced platelet activation and protein kinase C dependent responses. 1988 Biochem. Biophys. Res. Commun. pmid:2847730
Yoshizumi M et al. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. 1990 Biochem. Biophys. Res. Commun. pmid:2405848
Wirthmueller U et al. Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a. 1991 Biochem. Biophys. Res. Commun. pmid:1645549
Alonso MT et al. Monitoring of the activation of receptor-operated calcium channels in human platelets. 1989 Biochem. Biophys. Res. Commun. pmid:2546547
Kroegel C et al. Evidence for two platelet activating factor receptors on eosinophils: dissociation between PAF-induced intracellular calcium mobilization degranulation and superoxides anion generation in eosinophils. 1989 Biochem. Biophys. Res. Commun. pmid:2546554
Corl CM et al. Oxidant stress enhances Lyso-PAF-AcT activity by modifying phospholipase D and phosphatidic acid in aortic endothelial cells. 2003 Biochem. Biophys. Res. Commun. pmid:12615078